Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells

Autor: Xi Chen, Qiang Lin, Zhao Li, Xiaobo Yu, Liwen Xiong, Wenzhuo Zhu
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Pathology
Lung Neoplasms
Carcinogenesis
Apoptosis
Kaplan-Meier Estimate
NSCLC
medicine.disease_cause
Metastasis
0302 clinical medicine
Cell Movement
Carcinoma
Non-Small-Cell Lung

RNA
Small Interfering

Aged
80 and over

STK39
Cell Cycle
High-Throughput Nucleotide Sequencing
Middle Aged
Cell cycle
Flow Cytometry
Prognosis
Up-Regulation
Oncology
Lymphatic Metastasis
030220 oncology & carcinogenesis
Female
RNA Interference
Research Paper
Adult
medicine.medical_specialty
MAP Kinase Signaling System
proliferation
Down-Regulation
Protein Serine-Threonine Kinases
Malignancy
03 medical and health sciences
Cell Line
Tumor

Biomarkers
Tumor

medicine
Humans
metastasis
RNA
Messenger

Lung cancer
neoplasms
Aged
Cell Proliferation
Neoplasm Staging
Oncogene
Sequence Analysis
RNA

business.industry
Cell growth
Gene Expression Profiling
Cancer
Oncogenes
medicine.disease
respiratory tract diseases
030104 developmental biology
Cancer research
business
Zdroj: Oncotarget
ISSN: 1949-2553
Popis: // Zhao Li 1, * , Wenzhuo Zhu 1, * , Liwen Xiong 2 , Xiaobo Yu 1 , Xi Chen 1 , Qiang Lin 1 1 Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China 2 Department of Pulmonary Diseases, Shanghai Chest Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China * These authors contributed equally to this work Correspondence to: Qiang Lin, email: xklinqiang@hotmail.com Keywords: STK39, NSCLC, proliferation, metastasis Received: June 07, 2016 Accepted: July 30, 2016 Published: August 17, 2016 ABSTRACT Non-small cell type lung cancer (NSCLC) is the most common malignancy and the leading cause of cancer related mortality. In this study, serine/threonine kinase 39 (STK39) was identified as an up-regulated gene in NSCLC tissues by next-generation RNA sequencing. Although STK39 gene polymorphisms may be prognostic of overall survival in patients with early stage NSCLC, the roles of STK39 in NSCLC cancer are poorly understood. In the current study, Genome Set Enrichment Analysis (GSEA) on the RNA-seq data of NSCLC specimens indicated that cancer-related process and pathways, including metastasis, cell cycle, apoptosis and p38 pathway, were significantly correlated with STK39 expression. STK39 expression was significantly increased in NSCLC cases and its protein expression was positively correlated with the poor tumor stage, large tumor size, advanced lymphnode metastasis and poor prognosis. Down-regulation of STK39 in NSCLC cells significantly decreased cell proliferation by blocking of cell cycle and inducing apoptosis. We also found that STK39 knockdown in NSCLC cells remarkably repressed cell migration and invasion. On the contrary, overexpression of STK39 in NSCLC cells had inverse effects on cell behaviors. Taken together, STK39 acts as a tumor oncogene in NSCLC and can be a potential biomarker of carcinogenesis.
Databáze: OpenAIRE